The Predictive Value of Three Variables in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis

BACKGROUND: Sex, age, and International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic risk may influence the immune response. Nonetheless, the correlation between these factors and the survival benefits of immune-based combination therapies in patients with metastatic renal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Min, Xing, Haiyan, He, Shuangshuang, Yang, Xue, Peng, Dan, Li, Yang, Zhang, Qing, Zhang, Pan, Ma, Yunqi, Li, Juan, Shan, Jinlu, Liu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482552/
https://www.ncbi.nlm.nih.gov/pubmed/36124031
http://dx.doi.org/10.1155/2022/7733251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482552/
https://www.ncbi.nlm.nih.gov/pubmed/36124031
http://dx.doi.org/10.1155/2022/7733251

Ejemplares similares